CYSTIC FIBROSIS FOUNDATION
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$4,986,222,387
Investments
96%
Cash & Equivalents
2%
Other Assets
1%
Receivables (Non-Related)
<1%
Property, Plant, & Equipment (net)
<1%
Prepaid Expenses
<1%
Inventories
<1%
Related-Party Receivables
0%
Liabilities in 2024 (Year End)
$292,597,881
Grants Payable
78%
Payables & Accruals
13%
Other Liabilities
8%
Deferred Revenue
<1%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$109,107,327
$93,147,571
-15%
Receivables (Non-Related)
$37,438,597
$35,719,363
-5%
Related-Party Receivables
-
$0
-
Inventories
$206,966
$126,801
-39%
Prepaid Expenses
$4,831,329
$5,773,137
+19%
Investments
$4,558,263,574
$4,788,488,570
+5%
Property, Plant, & Equipment (net)
$8,863,037
$9,729,248
+10%
Other Assets
$167,210,292
$53,237,697
-68%
Total Assets
$4,885,921,122
$4,986,222,387
+2%
Liabilities
2023
2024
Change
Payables & Accruals
$37,939,543
$39,199,190
+3%
Grants Payable
$226,220,440
$228,373,004
+1%
Deferred Revenue
$2,685,701
$2,877,223
+7%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
$0
-
Other Liabilities
$26,119,138
$22,148,464
-15%
Total Liabilities
$292,964,822
$292,597,881
0%
Net assets
2023
2024
Change
Restricted Net Assets
$16,855,249
$20,099,775
+19%
Unrestricted Net Assets
$4,576,101,051
$4,673,524,731
+2%
Net assets
2023
2024
Change
Net assets
+$4,592,956,300
+$4,693,624,506
+2%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)